Podcasts

OUTSPOKEN ONCOLOGY

Episode 32: AYA Challenges and Opportunites With Mark Lewis

05/03/2022

Mark A Lewis, MD, attempts to classify the AYA patient population, explain the disconnect of clinical trial accrual in this population, and pose social media as a critical avenue for overcoming this barrier.

Mark A Lewis, MD, attempts to...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 31: Business of Cancer Care With CTCA CEO Pat Basu

05/03/2022

Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America, shares with Chadi his unique experience of combining the clinical health care discipline with business and policy.

Pat Basu, MD, MBA, president and...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 30: From Academia to Startup CEO With Sekar Kathiresan

05/03/2022

Sekar Kathiresan, MD, sits down with Chadi to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics.

Sekar Kathiresan, MD, sits down...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 29: Convergence of Politics and Medicine With Saurabh Jha

05/03/2022

Opinions collide in this spirited debate about how physicians can and should enter conversations on political issues as Chadi and returning guest Saurabh Jha expound on a recent Lancet article focused on the Kashmir conflict.

Opinions collide in this...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 28: Advances in NSCLC With Nathan Pennell

05/03/2022

Nathan Pennell, MD, PhD, and Chadi deliberate on some timely topics in NSCLC, including screening, adjuvant therapy, metastatic disease, and ensuring patient adherence to oral therapies.

Nathan Pennell, MD, PhD, and...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 27: Hospitalists and Modern Cancer Care With Rebecca Berger

05/03/2022

Rebecca Berger, MD, discusses the dilemma of oncology patient handoffs as well as the physician-to-hospitalist relationship.

Rebecca Berger, MD, discusses...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 26: Utilizing Big Data and EMRs With Jeremy Warner

05/03/2022

Jeremy Warner, MD, MS, describes big data, explains how medical errors were part of the impetus toward EMR popularization, and projects the future of EMRs and interoperability.

Jeremy Warner, MD, MS, describes...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 25: Advances in Radiation Oncology With Matthew Katz

05/03/2022

Matthew Katz, MD, provides the distinguishing factors between all forms of radiation therapy used in oncology today, including brachytherapy, SBRT, hypofractionated radiation therapy, and proton therapy, among others.

Matthew Katz, MD, provides the...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 24: Gender Bias and Challenges for Women in Academic Medicine With Narjust Duma

05/03/2022

Narjust Duma, MD, thoracic oncologist at the University of Wisconsin, enlightens Chadi on gender bias in academic medicine, challenges facing women mentees, and her provocative research presentation at the recent ASCO annual meeting.

Narjust Duma, MD, thoracic...

05/03/2022

Journal of Clinical Pathways

OUTSPOKEN ONCOLOGY

Episode 23: Improving End-of-Life Care With Jeremy Topin

05/03/2022

Jeremy Topin, MD, delves into a conversation with Chadi that focuses on improving communication in end-of-life care and the societal shift necessary to change the negative stigma surrounding such care.

Jeremy Topin, MD, delves into a...

05/03/2022

Journal of Clinical Pathways